Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
5.94
-0.18 (-2.94%)
At close: Oct 21, 2026, 4:00 PM EDT
6.07
+0.13 (2.19%)
Pre-market: Oct 22, 2026, 7:21 AM EDT

Clearmind Medicine Financials Overview

Millions USD. Fiscal year is Nov - Oct.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Operating Income
-8.87-5.67-5.74-6.3-6.25-2.97
Net Income
-7.5-3.86-5.25-8.62-6.89-3

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Investments
15.935.596.865.510.323.71
Total Debt
1.81.780.05-0.04-
Net Cash (Debt)
14.133.816.815.510.283.71
Net Cash Growth
307.47%-44.10%23.51%1840.56%-92.34%1396.58%

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Operating Cash Flow
-7.07-4.73-4.86-6.3-3.72-2.29
Capital Expenditures
-----0.01-0.03
Free Cash Flow
-7.07-4.73-4.86-6.3-3.73-2.31
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.